Ashleigh Xie1, Phillip Lo1, Tristan D Yan2, Paul Forrest3. 1. The Collaborative Research Group, Macquarie University, Sydney, Australia; University of New South Wales, Sydney, Australia. 2. The Collaborative Research Group, Macquarie University, Sydney, Australia; Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. 3. Sydney Medical School, University of Sydney, Sydney, Australia; (‖)Department of Anaesthetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: paul.forrest@sydney.edu.au.
Abstract
OBJECTIVE: To review the evidence on neurologic complications in adult extracorporeal membrane oxygenation (ECMO) patients with regard to incidence, pathophysiology, risk factors, diagnosis, monitoring techniques, prevention, and management. DESIGN: Literature review. SETTING: Observational studies and case reports from a variety of institutions. PARTICIPANTS: Adult ECMO patients. INTERVENTIONS: Six electronic databases were searched from their dates of inception to October 2016. MEASUREMENTS AND MAIN RESULTS: The range of neurologic complications reported in adult ECMO patients included stroke, intracranial hemorrhage, and brain death. Due to a lack of standardized reporting, their true incidence may have been underestimated significantly. A variety of pathophysiologic mechanisms and risk factors have been proposed. Some of these are specific to venoarterial ECMO, whereas others may be more relevant to venovenous ECMO (eg, rapid correction of hypercarbia). With regard to diagnosis and monitoring, clinical examination alone can be challenging and insufficiently sensitive, particularly for the confirmation of brain death. Computed tomography is the main imaging modality for acute neurologic assessment because magnetic resonance imaging is not feasible in these patients. Options for neuromonitoring are limited, although cerebral near-infrared spectroscopy may be useful. There are very limited data to guide the management of specific complications such as intracranial hemorrhage, which remains a leading cause of mortality in ECMO patients. CONCLUSIONS: ECMO can be lifesaving and is being used increasingly for severe respiratory and/or cardiac failure. However, it remains associated with significant neurologic morbidity and mortality. Greater research clearly is needed to determine the best approach to the assessment and management of neurologic complications in this rapidly growing patient population.
OBJECTIVE: To review the evidence on neurologic complications in adult extracorporeal membrane oxygenation (ECMO) patients with regard to incidence, pathophysiology, risk factors, diagnosis, monitoring techniques, prevention, and management. DESIGN: Literature review. SETTING: Observational studies and case reports from a variety of institutions. PARTICIPANTS: Adult ECMO patients. INTERVENTIONS: Six electronic databases were searched from their dates of inception to October 2016. MEASUREMENTS AND MAIN RESULTS: The range of neurologic complications reported in adult ECMO patients included stroke, intracranial hemorrhage, and brain death. Due to a lack of standardized reporting, their true incidence may have been underestimated significantly. A variety of pathophysiologic mechanisms and risk factors have been proposed. Some of these are specific to venoarterial ECMO, whereas others may be more relevant to venovenous ECMO (eg, rapid correction of hypercarbia). With regard to diagnosis and monitoring, clinical examination alone can be challenging and insufficiently sensitive, particularly for the confirmation of brain death. Computed tomography is the main imaging modality for acute neurologic assessment because magnetic resonance imaging is not feasible in these patients. Options for neuromonitoring are limited, although cerebral near-infrared spectroscopy may be useful. There are very limited data to guide the management of specific complications such as intracranial hemorrhage, which remains a leading cause of mortality in ECMO patients. CONCLUSIONS: ECMO can be lifesaving and is being used increasingly for severe respiratory and/or cardiac failure. However, it remains associated with significant neurologic morbidity and mortality. Greater research clearly is needed to determine the best approach to the assessment and management of neurologic complications in this rapidly growing patient population.
Authors: Michael M Koerner; Michael D Harper; Christopher K Gordon; Douglas Horstmanshof; James W Long; Michael J Sasevich; James D Neel; Aly El Banayosy Journal: Ann Cardiothorac Surg Date: 2019-01
Authors: Prakash Acharya; William A Jakobleff; Stephen J Forest; Thiru Chinnadurai; Nicolas Mellas; Snehal R Patel; Jorge R Kizer; Henny H Billett; Daniel J Goldstein; Ulrich P Jorde; Omar Saeed Journal: ASAIO J Date: 2020-03 Impact factor: 3.826
Authors: Imad R Khan; Yang Gu; Benjamin P George; Laura Malone; Kyle S Conway; Fabienne Francois; Jack Donlon; Nadim Quazi; Ashwin Reddi; Cheng-Ying Ho; Daniel L Herr; Mahlon D Johnson; Gunjan Y Parikh Journal: Neurology Date: 2021-01-20 Impact factor: 9.910
Authors: Adamantios Tsangaris; Tamas Alexy; Rajat Kalra; Marinos Kosmopoulos; Andrea Elliott; Jason A Bartos; Demetris Yannopoulos Journal: Front Cardiovasc Med Date: 2021-07-07
Authors: Alexander Fletcher-Sandersjöö; Eric Peter Thelin; Jiri Bartek; Mikael Broman; Marko Sallisalmi; Adrian Elmi-Terander; Bo-Michael Bellander Journal: Front Neurol Date: 2018-07-06 Impact factor: 4.003
Authors: David Hong; Ki Hong Choi; Yang Hyun Cho; Su Hyun Cho; So Jin Park; Darae Kim; Taek Kyu Park; Joo Myung Lee; Young Bin Song; Jin-Oh Choi; Joo-Yong Hahn; Seung-Hyuk Choi; Jin-Ho Choi; Kiick Sung; Hyeon-Cheol Gwon; Eun-Seok Jeon; Jeong Hoon Yang Journal: Ann Intensive Care Date: 2020-06-16 Impact factor: 6.925